`
`4%
`
`: Env
`
`Home News & Mada Press Releases
`
`U.S. FDA Approves Eliquis (apixaban) for the Treatment of Deep Vein Thrombosis (DVT) and Pulmonary Embolisrn (PE). and for
`the Reduction in the Risk of Recurrent DVT and PE Following Initial Therapy
`
`> m&AM1EYm
`> E¢Bdnm5mndspahiqhdnphnynieqaujuh1dnqaHufigmn5an1qaWhuhhhfirMMEYnfl
`Th|Isday,August21,201lu-131pmEDT
`Bristol-Myers Squibb Company(NVSE'BMY)uId Pfizerlnc MYSE:PFBmdaymrmumedfluU5.FoodaIdIkugAdmidflImbn(FDA)hasIppImeda
`SIpp|emelmaINeurl)rugAppicaIion(slI)A)forfltp-SforlhctrealnentofnvfandPE.aIdfonhereductionhtheIiiofrcmnemDVTmIdPEfoIuuiIghiiaI
`theIupy.CorIIhi|ed.UVl'ImdPEa'etnownasVIE.nEe§irIkmeddntaayyeu,q)pmximte|y900.0IDMnrtamu!afiechedbyDWumPE
`
`‘WeamepleasedlhatEquisisllnravaildfleasaneffectiwetrectrlielltoptialfu'DVTalIdPE.'saidDwgasMaIi>n,MD,IleadofSpedaltyDevdoptnem.
`BIBmFMye5SqIbh‘&|Bdfusmd¢5i|g_mmnfiumagflafiuIt5fiIg_umdo5nmmq|iednInseafaparuileltllarlfiooaginlaltorbridfilgduilig
`initiation.‘
`
`"DVT,wlI‘dImay|eadtoPE,cuIkaurbmmdiuimldfiuxwflwfiltqwigimmfitemdbalmmfionhrmmmmmxeavfihummnd,
`appronnataely‘ Bperceritofptnietlsaeatriskofareainulcewitiil 10years.'saiiSt:veRoIru1II>.serIiorvicepresrdetIL' llerldofucdidllesoeveloprnent
`GrmpfmGbbdlmavafivePIunIunmfiaab,PfizuhK.'TheBIimnl-MyessqiibbuldPfizercimteisoormitmadmdeivuilginpommtuaahlielitopnionsm
`
`1'hefI.IIPr¢saibinglrIfaInanan' forflqlns’'i1dudesBonedW¢l'rI1gs' forthei|cmasedIiskoftlIroni1ohc' evemsinpahents’ wl1opmn|atu'dydIs4:oIll'I'’uefl¢us'‘
`aridftxtheirxzreasedriskofcpidtudotsphdlmImmmMidIrmym|mhq—mmupumumtmmysB.hmfiun|5iIgEEqrisammdergargspiu
`q)iduIuIanesthes'aarspindptl|ctme_
`
`Efquisilaeaseslherishbfbiecqirlgmdcmumseseriougpouernialyfaml,bkcding.Pk¢5escefinam1fleteBondWwringsmdaddtbrn|lnponamSafety
`Infonnationintlispresreleasa
`
`TheFlMq)[Iovdtf&qIisfmfl|euummmnfDWmIdPEmIdfixfl|eredIxfiorIhflIefisk4fre<urUtDWmflPEfoImui1giIiIidtherupy,isbascdondata
`fromtheg|obdAlDl.IFVuIdAMPl.IFY-EX'I'studies_
`
`TheAMPLIFVstudy.amdmndfiubbbhflumwudaymdwknmmmefludfiuxymflsfiuydflydshflnnumrundnwmflPE.and
`includedpatiemswithcolfinnedsymptomaticDVTorPE(2_flBfarE1pBa1d2,635fm$nndaMofaIgMimw|ui1ihlqmmpamumunatfamka1
`fiveduys,over|apped IrywurfIxintheI'Iq1y[lmenIation1I|NomIaliud|UaIio(IlIl) IuIge2.0-3.0]<xuIyforsixrnorII!Is).
`
`InIheAMPl]FYstudy,fl'(pis10mgtwicedaiyforoneweekfol|awedbysnlgtwkedaiyfixixnmtfllsdermmuuteddficncyuunpaaflemstuidardofmm
`intmatilgDVTmflKpmbmfixflnpimqefikmym1vo§&afimflfirxunut,ynmmmdicWEuWHehmddmflI(23365.2.7%,re|diverisk,
`0.84; 95)6canfiden(einteIvuI [(3], 0.60110 1.18:!’-vdue<0.0001
`
`Efiprbdulmsummmpahiyhfluphmqmfiqaufiximdrmprbkefigwnsflardwddmewfifiw.1.8%,rel|1iverisk031:9536CI.0.17tn0.55;
`P<0_0001 forsuperiority)_Maprhleecingwasdefimedmciicdlymatbhedingflutw¢5maxrpmkdbymnmnmedflnfoIawi1g:adeauseinflm
`halmgobhlevdoflgldornlxezauunsfusionoftwnornuxeuritsofpadedledbloodcelsbleedilgdtatocnnredilatleastumeofdnefolowingaifical
`sis:htmannial,im$iuLirmmmh_@umflimamhr_immmmhMmmnwumm$uum, ;mbkfiqflmwmfim
`
`Fafln2cmflmymffiya|qmmhfluMDlJYmfly,fltenmrm5fmdiriaIyrebmmmm'u]uNeeGq (CRNM)werefewer'nEqui9|Ieatedp1tiems
`comparedmsunthtdofcate-tremedpatiens(3.93Iv18.03I).Ckfluwmdefimdcsmenbhedngflutdidmxlmetflnaimrhforrrmjubhadhghnwas
`assodatedwitham&dflamfimmImdfimawpfim.humflm1dflnmflymgatmrhnMhpfinHthmnfigomfiymfivfi5.
`InAMPI.IFV,the¢ismm'nuationInteduelohkdigennBwm0.7XhflnEwbmmedp¢ErnmIpaiMm1_7%muumpafiNmflanwummdpa&nB.
`
`Aho
`
`mpjlwwwmzer_canInarIsIpress-releaseIpress-release-dd:IIu_s_k‘h_qiproves_eliqis_q1ixz«mm_ir_Ihe_I|'edrnert_d‘_deep_vein_Iranbosis_¢M_a|a
`
`1I4
`
`Page 1 of 1
`
`SENJU
`
`EXHIBIT 2300
`
`LUPIN V. SENJU
`
`IPR20l5-01099